Strut Health review

Two formats, two different buying decisions

Strut lists a compounded semaglutide injectable vial at $129 per month and a buccal lozenge at $199 for a 30-day supply. Physician consultations and shipping are included in the displayed prices. Those are useful starting points for a comparison, provided the final prescription and price match your clinical situation. ^[1]

I would put Strut on a shortlist for a reader who wants an online metabolic-care evaluation and understands the product being offered. I would not pay the higher lozenge price merely because avoiding an injection sounds easier. Convenience matters, but the route, formulation and supporting evidence belong in the same decision. A familiar ingredient name does not settle those questions.

The prescription should have a purpose beyond the scale

A healthspan purchase needs a specific problem to solve. Weight, physical function, blood pressure and cardiovascular disease are related concerns, but they are not interchangeable endpoints. An attractive treatment menu does not establish that every person with an interest in healthy aging benefits from medication.

For example, SELECT tested weekly injected semaglutide in people with established cardiovascular disease and overweight or obesity without diabetes. That is meaningful evidence for its population and product; it does not demonstrate that Strut's compounded preparations extend life in healthy adults. ^[2] Take the question you want answered into the consultation rather than treating the service's wider wellness menu as a reason to add treatments.

The distinction becomes clearer in what SELECT actually established.

The follow-up is part of the product

Strut advertises provider messaging and follow-ups, with medication delivered to the home. It also describes auto-refill and cancellation availability. ^[1] Those features could reduce the practical burden of an ongoing plan, especially for someone balancing treatment with work and family commitments.

The useful question is how that access works when the plan changes. Establish who responds to a side-effect report, how medication changes are approved and which problems require local care. Messaging access is not the same as emergency coverage. Keep your usual clinicians informed about prescriptions from another service so the medication list and relevant monitoring remain connected.

The regulatory history deserves a clear place

FDA issued a February 20, 2026 warning letter to Strut concerning misleading compounded-drug claims and labeling that suggested Strut was the compounder. The letter distinguishes compounded products from FDA-approved drugs and asks for corrective action. It does not establish the outcome of every later prescription or tell us whether the concerns have since been resolved. ^[3]

That history changes what I would want before ordering: the dispensing pharmacy's identity, the precise formulation and a clear explanation of why a compounded preparation is appropriate. A licensed prescriber and an appealing website do not remove the need for those answers. Nor should the letter be stretched into an unsupported claim that an individual shipment is defective.

A low opening bill should lead to a sustainable plan

Judge Strut against the full care arrangement, including what happens after the first period. A manageable recurring cost, a workable contact channel and coordination with existing care matter more than adding another impressive metric to a dashboard. Make sure the product and quantity in the prescription correspond to the offer you compared.

My choice would turn on the formulation and the ability to sustain clinically appropriate care. If you want another online quote, compare the same service components at HealthRX rather than comparing a starting offer with a renewal bill. The account should make the next clinical conversation easier to arrange, rather than becoming another subscription that runs without a clear purpose. If the motivation is simply to become biologically younger, step back: this purchase needs a medical rationale before it needs a discount.

For a second service and renewal-price comparison, use our HealthRX review.

Understanding the cost

Displayed compounded semaglutide: $129/month injectable vial or $199/30-day buccal lozenge, including consultations and shipping; final prescription and pricing require consultation. ^[1]